Lumexa Imaging Holdings, Inc.’s (NASDAQ:LMRI) Lock-Up Period Set To Expire on June 9th

Lumexa Imaging’s (NASDAQ:LMRI) lock-up period is set to end on Tuesday, June 9th. Lumexa Imaging had issued 25,000,000 shares in its public offering on December 11th. The total size of the offering was $462,500,000 based on an initial share price of $18.50. Shares of the company owned by company insiders and major shareholders will be eligible for trade following the expiration of the lock-up period.

Analyst Upgrades and Downgrades

A number of research analysts recently weighed in on the stock. Weiss Ratings assumed coverage on shares of Lumexa Imaging in a research note on Wednesday, May 13th. They issued a “sell (e-)” rating for the company. Raymond James Financial upgraded shares of Lumexa Imaging from an “outperform” rating to a “strong-buy” rating and set a $23.00 price objective for the company in a research note on Monday, February 9th. Finally, Barclays reduced their price objective on shares of Lumexa Imaging from $15.00 to $9.00 and set an “overweight” rating for the company in a research note on Wednesday, May 20th. One investment analyst has rated the stock with a Strong Buy rating, one has assigned a Buy rating and one has given a Sell rating to the company. Based on data from MarketBeat.com, Lumexa Imaging has an average rating of “Moderate Buy” and a consensus price target of $16.00.

Lumexa Imaging Stock Down 5.5%

LMRI opened at $7.35 on Tuesday. The firm’s fifty day moving average price is $9.04. Lumexa Imaging has a one year low of $6.45 and a one year high of $19.45.

Insider Activity at Lumexa Imaging

In other news, Director Brett Brodnax purchased 35,000 shares of Lumexa Imaging stock in a transaction dated Tuesday, May 19th. The stock was purchased at an average cost of $7.25 per share, for a total transaction of $253,750.00. Following the transaction, the director directly owned 62,027 shares of the company’s stock, valued at approximately $449,695.75. This trade represents a 129.50% increase in their ownership of the stock. The purchase was disclosed in a document filed with the SEC, which is available through this hyperlink. 0.70% of the stock is owned by company insiders.

Institutional Inflows and Outflows

Hedge funds and other institutional investors have recently added to or reduced their stakes in the stock. Assetmark Inc. purchased a new position in Lumexa Imaging in the fourth quarter worth $36,000. Strs Ohio purchased a new position in Lumexa Imaging in the first quarter worth $38,000. Barclays PLC purchased a new position in Lumexa Imaging in the fourth quarter worth $133,000. PNC Financial Services Group Inc. purchased a new position in Lumexa Imaging in the first quarter worth $63,000. Finally, Sandia Investment Management LP purchased a new position in Lumexa Imaging in the fourth quarter worth $185,000.

Lumexa Imaging Company Profile

We are one of the largest national providers of diagnostic imaging services(1). Our platform is integrated, scalable and has a proven track record of creating value for our stakeholders. As of September 30, 2025, we and our affiliates operated the second largest(1) outpatient imaging center footprint in the United States. It spans 184 centers(2)across 13 states and includes eight joint venture partnerships with health systems. Our centers are in attractive metropolitan statistical areas (“MSAs”).